Characteristics and Outcomes of Adult Patients with T Prolymphocytic Leukemia: A Real World Study of the French Innovative Leukemia Group (FILO)

MLA

Laribi, Kamel, et al. “Characteristics and Outcomes of Adult Patients with T Prolymphocytic Leukemia: A Real World Study of the French Innovative Leukemia Group (FILO).” Blood, vol. 140, no. 1, Number 1 Supplement 1, Nov. 2022, pp. 1485–87. EBSCOhost, https://doi.org/10.1182/blood-2022-157399.

APA

Laribi, K., Ysebaert, L., Inchiappa, L., Villemagne, B., Guillermin, Y., Paillassa, J., Merabet, F., Guénot, C., Baugier de Materre, A., Herbaux, C., Mahe, K., Divoux, M., Algrin, C., Lepretre, S., Roos Weil, D., Tomowiak, C., Ghez, D., Poulain, S., Loirat, M., … Bene, M. C. (2022). Characteristics and Outcomes of Adult Patients with T Prolymphocytic Leukemia: A Real World Study of the French Innovative Leukemia Group (FILO). Blood, 140(1, Number 1 Supplement 1), 1485–1487. https://doi.org/10.1182/blood-2022-157399

Chicago

Laribi, Kamel, Loic Ysebaert, Luca Inchiappa, Bruno Villemagne, Yann Guillermin, Jérôme Paillassa, Fatiha Merabet, et al. 2022. “Characteristics and Outcomes of Adult Patients with T Prolymphocytic Leukemia: A Real World Study of the French Innovative Leukemia Group (FILO).” Blood 140 (1, Number 1 Supplement 1): 1485–87. doi:10.1182/blood-2022-157399.